Trial PaperDepressive DisordersMajor Depressive Disorder (MDD)Neuroimaging & Brain MeasuresPsilocybin

Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment

Using whole‑brain models guided by the thermodynamics of mind, the authors perturb model parameters to estimate brain hierarchy and quantify state susceptibility and drivability in major depressive disorder before and after psilocybin or escitalopram treatment. They find escitalopram reduces susceptibility while psilocybin increases it, yet both treatments promote transitions to healthier states, demonstrating the models' potential to inform in‑silico neurostimulation protocols for neuropsychiatric disorders.

Authors

  • Robin Carhart-Harris
  • David Nutt
  • David Erritzoe

Published

Annals of the New York Academy of Sciences
individual Study

Abstract

Determining the scale of neural representations is a central challenge in neuroscience. While localized representations have traditionally dominated, evidence suggests information is also encoded in distributed, hierarchical networks. Recent research indicates that the hierarchy of causal influences shaping functional patterns serves as a signature of distinct brain states, with implications for neuropsychiatric disorders. Here, we first explore how whole‐brain models, guided by the thermodynamics of mind framework, estimate brain hierarchy and how perturbing such models enables the study of in‐silico transitions represented by static functional connectivity. We then apply this to major depressive disorder, where different brain hierarchical reconfigurations emerge following psilocybin and escitalopram treatments. We build resting‐state whole‐brain models of depressed patients before and after interventions and conduct a dynamic sensitivity analysis to explore brain states’ susceptibility—measuring their capacity to change—and their drivability to healthier states. We show that susceptibility is on average reduced by escitalopram and increased by psilocybin, and that both treatments promote healthier transitions. These results align with the post‐treatment window of plasticity opened by serotonergic psychedelics and the similar clinical efficacy of both drugs in trials. Overall, this work demonstrates how whole‐brain models of brain hierarchy can inform in‐silico neurostimulation protocols for neuropsychiatric disorders.

Available with Blossom Pro

Research Summary of 'Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment'

Introduction

Understanding the scale at which the brain represents information—localised single neurons versus distributed hierarchical networks—remains a central challenge. Earlier research using fMRI, MEG and diffusion tractography has shown that functional connectivity (FC) and structural connectivity (SC) capture distributed network organisation, and graph-theoretical approaches have revealed features such as modularity and small-worldness. However, symmetric FC alone does not resolve the causal, hierarchical relationships between regions. To address this, the thermodynamics of mind framework links temporal irreversibility in neural time series to hierarchical, directional information flow; incorporating such asymmetry into generative whole-brain models produces generative effective connectivity (GEC) that aims to identify mechanistic drivers of functional hierarchy.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

References (15)

Papers cited by this study that are also in Blossom

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

Vohryzek, J., Cabral, J., Lord, L. D. et al. · Brain Communications (2024)

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
Serotonin and brain function: a tale of two receptors

Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)

Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)

927 cited
Increased global integration in the brain after psilocybin therapy for depression

Daws, R. E., Timmermann, C., Giribaldi, B. et al. · Nature Medicine (2022)

Dynamic coupling of whole-brain neuronal and neurotransmitter systems

Kringelbach, M. L., Cruzat, J., Cabral, J. et al. · PNAS (2020)

238 cited
Psychedelics

Nichols, D. E. · Pharmacological Reviews (2016)

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Vargas, M. V., Dunlap, L. E., Dong, C. et al. · Science (2023)

330 cited
Show all 15 references
How do psychedelics work?

Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)

Towards an understanding of psychedelic-induced neuroplasticity

Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)

Effects of classic psychedelic drugs on turbulent signatures in brain dynamics

Cruzat, J., Perl, Y. S., Escrichs, A. et al. · Network Neuroscience (2022)

19 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.

Perturbing whole-brain models of brain hierarchy:... — Research Summary & Context | Blossom